Keyword: GlaxoSmithKline (GSK)
Strategy & Management
07.10.2015
- Allotrope Foundation, an international consortium of pharmaceutical and biopharmaceutical companies with a common vision to develop innovative new approaches for handling data in R...
News
25.09.2015
- Following the green light from health regulator European Medicines Agency, the European Commission is expected to decide on a final approval for GlaxoSmithKline’s (GSK) injectable...
News
02.09.2015
- Fresh from completing its acquisition of GlaxoSmithKline’s OTC business, Ireland-domiciled pharmaceutical producer Perrigo has acquired ScarAway, a leading OTC scar management...
News
24.08.2015
- Novartis is acquiring all the remaining rights to GlaxoSmithKline’s (GSK) multiple sclerosis (MS) drug, Ofatumumab. A fully human monoclonal antibody which targets the CD20...
News
14.08.2015
- Drugs produced at a GlaxoSmithKline pharmaceutical plant in North Carolina closed earlier this week are safe, the company said, adding that production is due to restart by the...
News
13.08.2015
- GlaxoSmithKline has temporarily shuttered a plant in the US state of North Carolina that produces inhaled medications after routine testing found the bacteria that causes...
News
22.07.2015
- US drugmaker Pfizer has more collaborations with British universities than any other foreign company, according to the newly published Dowling Review conducted by Ann Dowling...
News
06.07.2015
- ViiV Healthcare, the HIV unit of GlaxoSmithKline, has signed an agreement with Shanghai-based Desano Pharmaceuticals under which the Chinese group will produce the active...
